Message Font: Serif | Sans-Serif
No. of Recommendations: 0
Titan Medical, Inc.(TITXF) is preparing to launch its surgical robot, Amadeus, for use in hospitals in 2015. Clinical trials start in 2013. It has one significant competitor, Da Vinci, a product of Intuitive Surgical, Inc.(ISRG). In approximately twelve
years ISRG rose from under 50.00/share to almost 600.00/share. Presently it is 489.20/share(07-26-2012). In three years TITXF has risen from under .50/share to 1.34/share(07-26-2012). It is possibly a diamond in the rough! Robotic surgery is the wave of the future. There is an Italian surgical robot and Korea has surgical robots, but if you research this topic and look at the data the only viable competitors in robotic surgery for our "Foolish" purposes are Da Vinci and Amadeus.
What do you, the "Foolish" community, think?
Johnson and Johnson (JNJ) has been communicating with Titan Medical, Inc
All stocks have to start somewhere. Who wants to be a millionaire?

Click here to see results so far.

Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.